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ABSTRACT
The replication of coronaviruses occurs in association with multiple virus-inducedmembrane structures that evolve during the
course of infection; however, the dynamics of this process remain poorly understood. Previous studies of coronavirus replica-
tion complex organization and protein interactions have utilized protein overexpression studies and immunofluorescence of
fixed cells. Additionally, live-imaging studies of coronavirus replicase proteins have used fluorescent reporter molecules fused to
replicase proteins, but expressed from nonnative locations, mostly late-transcribed subgenomic mRNAs, in the presence or ab-
sence of the native protein. Thus, the timing and targeting of native replicase proteins expressed in real time from native loca-
tions in the genome remain unknown. In this study, we tested whether reporter molecules could be expressed from the replicase
polyprotein of murine hepatitis virus as fusions with nonstructural protein 2 or 3 and whether such reporters could define the
targeting and activity of replicase proteins during infection. We demonstrate that the fusion of green fluorescent protein and
firefly luciferase with either nonstructural protein 2 or 3 is tolerated and that these reporter-replicase fusions can be used to
quantitate replication complex formation and virus replication. The results show that the replicase gene has flexibility to accom-
modate a foreign gene addition and can be used directly to study replicase complex formation and evolution during infection as
well as to provide highly sensitive and specific markers for protein translation and genome replication.
IMPORTANCE
Coronaviruses are a family of enveloped, positive-sense RNA viruses that are important agents of disease, including severe acute
respiratory syndrome coronavirus andMiddle East respiratory syndrome coronavirus. Replication is associated with multiple
virus-inducedmembrane structures that evolve during infection; however, the dynamics of this process remain poorly under-
stood. In this study, we tested whether reporter molecules expressed from native locations within the replicase polyprotein of
murine hepatitis virus as fusions with nonstructural proteins could define the expression and targeting of replicase proteins dur-
ing infection in live cells. We demonstrate that the replicase gene tolerates the introduction of green fluorescent protein or firefly
luciferase as fusions with replicase proteins. These viruses allow early quantitation of virus replication as well as real-timemea-
surement of replication complexes.
Coronaviruses (CoVs) are a family of RNA viruses that are im-portant agents of human and animal diseases (1), including
severe acute respiratory syndrome coronavirus (SARS-CoV) and
the recently emerged Middle East respiratory syndrome corona-
virus (MERS-CoV) (2–5). The genome of the CoV murine hepa-
titis virus (MHV) is one of the largest known replicating RNA
molecules, at 31.3 kb (1). The 5=-most replicase gene is composed
of two open reading frames (ORFs), ORF1a and ORF1b, and com-
prises approximately two-thirds of the genome. Translation be-
gins upon entry into a host cell, first of replicase ORF1a and then
of ORF1ab following a 1 ribosomal frameshift. The replicase
polyproteins are proteolytically processed by papain-like protease
1 (PLP1) and PLP2 in nsp3 and by the nsp5 protease (3CLpro) to
generate 16 nonstructural proteins (nsp1 to nsp16); functions in-
clude RNA-dependent RNA polymerase, helicase, primase, cap
methylation, and a novel proofreading exonuclease (1). The rep-
licase proteins nsp3, -4, and -6 have been demonstrated to be
involved in membrane modifications leading to the formation of
double-membrane vesicles (DMVs) (6). Each MHV nsp studied
has been shown to localize to virus-induced DMVs and other
modified host membranes, collectively referred to as replication
complexes (RCs) (7–13). While much has been learned about vi-
rus-induced host cell modifications, little is known of the process
of RC formation and how RCs change over time. It is known that
nucleocapsid is associated with new sites of RNA synthesis but also
sites of virus assembly in the endoplasmic reticulum-Golgi inter-
mediate compartment (ERGIC) and in the Golgi compartment
distinct from sites of replication (14). The mechanisms by which
RCs form, RNA synthesis occurs, and nucleocapsids transit to sites
of virion assembly, however, remain unknown.
To date, studies of CoV replication complex formation have
involved immunofluorescence imaging of fixed cells using anti-
bodies against native proteins (10, 12, 15, 16). For assessment of
kinetics of replication, fluorescent and luminescent reporters have
been expressed with either replicase proteins from expression
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plasmids, reporter proteins replacing nonessential accessory
ORFs, or replicase protein-reporter fusions expressed in place of
accessory ORFs (17–20). Reporters have also been utilized within
CoV replicon genomes (21). Studies with such constructs have
provided insights into the function and interaction of replicase
proteins during viral replication, and the constructs have also
served as reporters for studies of CoV inhibitors (21–24). While
these strategies have been useful for reports on overall virus rep-
lication, they were not designed to test the expression or localiza-
tion of specific proteins, nor were they designed to report replicase
gene expression. A replicase reporter virus has been constructed
for equine arteritis virus, an arterivirus with a genome size less
than half that of MHV, with the insertion of enhanced green flu-
orescent protein (EGFP) between nsp1 and nsp2 (25). The capac-
ity of the CoV replicase gene to accept foreign genes, however, is
not known, nor has foreign gene insertion within the replicase
gene of any replicating CoV been tested without a compensatory
deletion of viral genetic material. In this study, we describe the
quantitative measurement of MHV replicase gene expression and
the formation of replication complexes using engineered reporter
viruses expressing green fluorescent protein (GFP) and firefly lu-
ciferase (FFL) as in-frame fusions with viral replicase proteins
nsp2 and nsp3. nsp2 is a 65-kDa protein that has been shown to
localize to CoV replication complexes but is dispensable for virus
replication in culture (26). nsp3 is a 210-kDa protein that contains
two essential proteases and other functional protein domains and
is required for both virus-induced membrane modifications and
virus replication (6). We demonstrate that GFP and FFL reporter
fusions with nsp2 and nsp3 permit efficient virus replication, tar-
get replication complexes, provide the earliest indicators of MHV
replication, and allow direct measurements of replication com-
plex formation. These results also demonstrate the capacity of the
MHV genome to tolerate expansion and identify sites for possible
virus-mediated expression of foreign proteins within the replicase
polyprotein.
MATERIALS AND METHODS
MHV and previously described mutant viruses, cells, and antibodies.
Recombinant murine hepatitis virus strain A59 (GenBank accession
number AY910861) was used as the wild type (WT) for all experiments
(27, 28). MHV-nsp2, with an in-frame deletion of nsp2, and MHV-
CS2, with a deletion of the nsp2-3 cleavage site P1 Glu, were described
previously (26). Delayed brain tumor (DBT) cells (29) and baby hamster
kidney cells expressing the MHV receptor (BHK-MHVR) (30, 31) were
grown in Dulbecco’s modified Eagle medium (DMEM) that contained
10% fetal bovine serum (FBS), 1% 1 M HEPES, 100 units/ml of penicillin,
100 g/ml streptomycin, and 0.23 l/ml amphotericin B for all experi-
ments. Medium for BHK-MHVR cells was supplemented with G418 (0.8
mg/ml) for selection of cells expressing the receptor. The polyclonal anti-
bodies used in biochemical and imaging experiments were described pre-
viously. All polyclonal antibodies were raised in rabbits unless otherwise
indicated. For MHV, these included antibodies specific for nsp1 (VU221)
(16), nsp2 (VU154) (15), nsp3 (VU164) (26), and nsp8 (VU123) (11).
Mouse monoclonal anti-firefly luciferase (FFL), clone LUC-1, was pur-
chased from Sigma-Aldrich. Mouse monoclonal antibody specific for full-
length GFP was purchased from SantaCruz Biotechnology. Mouse mono-
clonal antibody against the viral membrane protein (M) was generously
provided by J. Fleming (University of Wisconsin, Madison).
Construction of mutant MHV cDNA plasmids. Insertions of re-
porter genes in place of the nsp2 coding sequences of MHV were engi-
neered by using PCR with primers shown in Table 1. For ABCDEF primer
sets, primers A and B generated an A/B PCR product, primers C and D
generated a C/D PCR product, and primers E and F generated an E/F PCR
product. AB, CD, and EF PCR amplicons were ligated into an ABCDEF
product by using the class IIs restriction enzyme method, and ligation
products were cloned into the appropriate fragment A vector by using
unique sites: 5=-SacII and 3=-NdeI. Successful insertions of reporter gene
sequences were confirmed by restriction digestion and sequencing. The
infectious cDNA fragment A construct (pCR-XL-Topo-A), which con-
sists of genome nucleotides (nt) 1 to 4882, was used as the template DNA
(33). Reporter genes were cloned from pEGFP-C1 (GFP; Clontech) and
pGEM-Luc (firefly luciferase; Promega).
Generation ofMHVmutant viruses. Viruses containing PCR-gener-
ated insertions within the viral coding sequence were produced by using
infectious cDNA assembly strategies for MHV as previously described,
with modifications (27, 28, 33, 34). Plasmids containing the seven cDNA
cassettes of the MHV genome were digested by using MluI, BsmBI, and
SfiI for fragment A; BglI and BsmBI for fragments B and C; BsmBI and
NciI for fragments D and E; BsmBI for fragment F; and BsmBI and SfiI for
fragment G. Digested, gel-purified fragments were ligated together in a
total reaction volume of 100 l overnight at 16°C. Following chloro-
form extraction and isopropanol precipitation of ligated DNA, capped,
polyadenylated, full-length RNA transcripts of MHV infectious cDNA
were generated in vitro by using the mMessage mMachine T7 transcrip-
tion kit (Ambion) according to the manufacturer’s protocol, with modi-
fications. Twenty-microliter reaction mixtures were supplemented with 3
l of 30 mM GTP, and transcription was performed at 40.5°C for 25 min,
37.5°C for 50 min, and 40.5°C for 25 min. In parallel, capped, polyade-
nylated RNA transcripts encoding the corresponding nucleocapsid (N)
proteins were generated in vitro by using N cDNA generated by PCR (33,
34). N transcripts and mutant viral transcripts were then mixed and elec-
troporated into BHK-MHVR cells. Cells were grown to subconfluence,
trypsinized, and then washed twice with phosphate-buffered saline (PBS)
and resuspended in PBS at a concentration of 107 cells/ml. Six hundred
microliters of cells was then added to RNA transcripts in a 4-mm-gap
TABLE 1 Primers used for generation of reporter insertions
Primer Sequencea Amplification target Sense Description
MHV A 5=-AACGGCACTTCCTGCGTGTCCATG MHV nsp1  Common MHV left nsp1 primer
MHV B 5=-CGTCTCCCTTAACACCGCGATAGCCCTTAAGAAGAG MHV nsp1  Common MHV right nsp1 primer
MHV-GFP C 5=-CGTCTCCTAAGATGGTGAGCAAGGGCGAGGAGCTGT GFP 
MHV-GFP D 5=-CGTCTCGTGCCCTTGTACAGCTCGTCCATGCCGAGAGT GFP  MHV-2-GFP3
MHV-GFP D 5=-CGTCTCGTAACCTTGTACAGCTCGTCCATGCCGAGAGT GFP  MHV-GFP2
MHV-FFL C 5=-CGTCTCCTAAGATGGAAGACGCCAAAAACATAAAGAAAG FFL 
MHV-FFL D 5=-CGTCTCGTGCCCAATTTGGACTTTCCGCCCTTCTT FFL  MHV-2-FFL3
MHV-FFL D 5=-CGTCTCGTAACCAATTTGGACTTTCCGCCCTTCTT FFL  MHV-FFL2
MHV E 5=-CGTCTCGTATCGCGGTGTTAAGAAAGTCGAGTTTAAC MHV nsp3  Common MHV left nsp3 primer
MHV F 5=-ACTTGCACATATGAGACACAACGTCCCCA MHV nsp3  Common MHV right nsp3 primer
a Underlining indicates residues added for cloning or mutagenesis purposes.
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electroporation cuvette (BTX), and three electrical pulses of 850 V at 25
F were delivered with a Bio-Rad Gene Pulser Xcell electroporator.
Transfected cells were then seeded onto a layer of 106 uninfected DBT cells
in a 75-cm2 flask and incubated at 37°C for 30 to 90 h. Virus viability was
determined by syncytium formation. RNA was recovered from infected
cell monolayers by using TRIzol (Invitrogen) according to the manufac-
turer’s instructions, and retention of the introduced mutations was veri-
fied by reverse transcription-PCR (RT-PCR) and sequencing.
Microscopy. DBT cells grown to 60% confluence on 12-mm glass
coverslips were infected with reporter viruses. At 10 h postinfection (p.i.),
medium was aspirated from cells, and cells were fixed and permeabilized
in methanol at20°C overnight. Cells were rehydrated in PBS for 20 min
and blocked in PBS containing 5% bovine serum albumin (BSA). Block-
ing solution was aspirated, and cells were washed with immunofluores-
cence (IF) assay wash solution (PBS containing 1% BSA and 0.05% Non-
idet P-40) at room temperature. Cells were incubated with primary
antibodies where indicated (anti-nsp8 at a 1:250 dilution, anti-M at
1:1,000, or anti-FFL [Sigma-Aldrich] at 1:1,000) for 45 min. Cells were
washed in IF wash solution 3 times for 5 min per wash. Cells were incu-
bated in secondary antibodies (goat anti-rabbit Alexa Fluor 488 [1:1,000]
or Alexa Fluor 546 [1:1,500]; Invitrogen Molecular Probes) for 30 min.
Cells were washed 3 times for 5 min per wash, followed by a final wash in
PBS, and then rinsed in distilled water. Coverslips were mounted with
Aquapolymount (Polysciences) and visualized by confocal immunofluo-
rescence microscopy on a Zeiss LSM 510 laser scanning confocal micro-
scope at 488 and 543 nm with a 40 oil immersion lens. Images were
processed and assembled by using Adobe Photoshop CS2 (9.0.2). For
live-cell fluorescence microscopy, DBT cells were seeded onto 35-mm
glass-bottom culture dishes (MatTek). Forty-eight hours later, cells were
infected with MHV-GFP2 at a multiplicity of infection (MOI) of 1 PFU/
cell. At 5 h p.i., plates were transferred to the live-cell incubator surround-
ing the objective stage of a Nikon Eclipse TE-2000S wide-field fluores-
cence microscope. Cells were imaged by using a 40 oil immersion lens
through differential interference contrast (DIC) and fluorescein isothio-
cyanate (FITC) filters, with images being captured at 30-s intervals over
the course of 4 h. Resulting images were merged and assembled by using
Nikon Elements, ImageJ, and Adobe Photoshop CS2.
Protein immunoprecipitations. For protein labeling and immuno-
precipitation experiments, cells were infected with MHV at an MOI of 10
and incubated at 37°C. At 4 h p.i., medium was aspirated and replaced
with medium lacking methionine and cysteine and supplemented with
actinomycin D (Sigma) at a final concentration of 20 g/ml. At 5 h p.i.,
cells were labeled with [35S]Met-Cys at a concentration of 0.08 mCi/ml.
Radiolabeled cells were lysed in 1 ml no-SDS lysis buffer (1% NP-40, 0.5%
sodium deoxycholate [DOC], 150 mM sodium chloride [NaCl], and 50
mM Tris [pH 8.0]) at 7 to 10 h p.i. Cellular debris and nuclei were pelleted
by centrifugation at 14,000 g for 3 min at room temperature (RT), and
the supernatant was transferred into a fresh tube. One hundred microli-
ters of cell lysate was subsequently used per 400 l of immunoprecipita-
tion reaction buffer. The lysate was combined with protein A-Sepharose
beads and a 1:200 dilution of antibody in no-SDS lysis buffer supple-
mented with 1% SDS. After incubation at 4°C for 18 h, beads were pelleted
and washed with low-salt lysis buffer (0.1% SDS lysis buffer with 150 mM
NaCl), followed by high-salt lysis buffer (no-SDS lysis buffer with 1 M
NaCl) and a final low-salt wash (0.5% SDS lysis buffer with 150
mM NaCl). After rinsing, proteins were eluted by the addition of 2 LDS
(lithium dodecyl sulfate)–1DTT (dithiothreitol) buffer (NuPage; Invit-
rogen) to the pelleted beads, which were heated at 70°C for 10 min prior to
electrophoresis of the supernatant on 4 to 12% Bis-Tris or 3 to 8% Tris-
acetate gels (NuPage; Invitrogen). A full-range rainbow ladder (GE
Healthcare) and a 14C ladder (PerkinElmer LAS) were used as molecular
weight standards.
Viral replication assays. For viral replication analysis, DBT cells were
infected in triplicate with WT MHV or mutant viruses at the MOIs indi-
cated for each experiment. Following a 30-min adsorption with rocking at
RT, medium was aspirated, and cells were washed 3 times with PBS and
then incubated with prewarmed medium at 37°C. Aliquots of medium
were collected from 0 to 24 h p.i., and virus titers were determined by
plaque assays on DBT cells in duplicate, as described previously (35).
Competition assay. Confluent monolayers of DBT cells in T25 flasks
were infected with WT MHV or MHV-GFP2 alone or at a 1:1, 1:10, or 10:1
ratio of WT MHV to MHV-GFP2 at a total MOI of 0.1 PFU/cell. Each flask
was passaged 10 times, as described above for serial virus passages, and 1
ml supernatant was collected and stored at80°C. DBT cells were seeded
onto glass coverslips and infected at an MOI of 1 PFU/cell with passage 1
(P1), P3, and P10 of each combination of viruses. At 8 h p.i., slides were
fixed with cold methanol (MeOH). Coverslips were immunostained with
primary antibodies specific for nsp8 and a secondary antibody, goat anti-
rabbit Alexa Fluor 546, as described above. Coverslips were mounted with
Aquapolymount (Polysciences) and visualized by immunofluorescence
microscopy on a Nikon Eclipse TE-2000S wide-field fluorescence micro-
scope. Cells were imaged by using a 40 oil immersion lens through DIC,
FITC, Cy3, and 4=,6-diamidino-2-phenylindole (DAPI) filters. The re-
sulting images were merged and assembled by using Nikon Elements,
ImageJ, and Adobe Photoshop CS2.
Luciferase activity versus viral replication assay. DBT cells in 6-well
plates were infected with MHV-2-FFL3 or MHV-FFL2 at an MOI of 1
PFU/cell and incubated at 37°C for 30 min. At 0.5 h p.i., medium was
aspirated to remove the inoculum, and cells were washed three times with
PBS and supplemented with prewarmed medium. At time points through
24 h p.i., the supernatant was harvested or cells were lysed in reporter lysis
buffer (Promega) and subjected to one freeze-thaw cycle. Following
freeze-thaw, lysates were vortexed and centrifuged briefly at top speed,
and supernatants were transferred into new tubes. To measure luciferase
activity, 20 l of lysate was added to each well of an opaque 96-well plate.
Plates were loaded onto a Chameleon luminometer, and an automatic
injector was used to add 100 l of reconstituted luciferase assay reagent
(Promega) to each well as the samples were being read, for 5 s per well
without delay. Viral replication was determined from harvested superna-
tants by a plaque assay, as described above.
RESULTS
Generation and recovery of MHV replicase reporter viruses.
Since nsp2 is dispensable for replication (26), we first tested the
tolerance for reporter expression in place of deleted nsp2. This
approach was also used because the engineered genome length
would not exceed that of WT MHV. We engineered constructs in
which enhanced green fluorescent protein (EGFP) (0.71 kb/26.8
kDa) or firefly luciferase (FFL) (1.65 kb/60.7 kDa) (Fig. 1) re-
placed the nsp2 coding sequence. All constructs were initially de-
signed with PLP1-specific cleavage sites at the N and C termini of
the reporter, based on the hypothesis that processing of the re-
porter from nsp1 and nsp3 would be required for viability. Fol-
lowing electroporation of in vitro-transcribed genome RNA into
BHK cells layered onto permissive DBT cells, cytopathic effect
(CPE) of syncytia was detected by 24 h postelectroporation for
both recombinant viruses. Medium supernatants from electropo-
rated cultures were used to infect fresh DBT cells, and RNA was
harvested and amplified by RT-PCR for sequencing of the entire
genome. Viral genome sequencing demonstrated the retention of
reporter genes without additional mutations in the genome. Pas-
sage of the P0 virus in culture demonstrated the stability of the
inserted GFP and FFL sequences for 5 passages (data not
shown). This confirmed the capacity of MHV to accept proteins of
differing sizes and structures in place of deleted nsp2. These vi-
ruses are referred to as MHV-2-GFP3 and MHV-2-FFL3. We
next determined the capacity of the MHV replicase to accept ad-
ditional genetic material into its genome without deletion of the
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viral sequence. GFP and FFL were engineered between nsp1 and
nsp2 while retaining all viral proteins. Since we sought to test
whether reporter fusions with nsp2 could be recovered, we re-
tained the cleavage site between nsp1 and the reporter but deleted
the cleavage site between the reporter and the nsp2 amino termi-
nus (Fig. 1B). Both recombinant viruses were recovered, their se-
quences were confirmed, and they were passaged for5 passages,
with retention of the introduced sequences (data not shown).
These viruses are referred to as MHV-GFP2 and MHV-FFL2.
Polyprotein expression and processing inMHV replicase re-
porter viruses. MHV-2-GFP3 and MHV-2-FFL3 mutant vi-
ruses were engineered with predicted functional cleavage sites at
the nsp1 and nsp3 junctions. To define the processing of nsp1-
reporter-nsp3 from the replicase polyprotein, DBT cells were in-
fected with WT MHV, MHV-2-GFP3, or MHV-2-FFL3 and
radiolabeled, and proteins were immunoprecipitated from lysates
of infected cells with antibodies specific for nsp1, -2, -3, and -8
(Fig. 2A). Immunoprecipitation of lysates from WT MHV-in-
fected cells detected nsp1, -2, -3, -2-3, and -8. Immunoprecipita-
tion of proteins from cell lysates of MHV-2-FFL3- and MHV-
2-GFP3-infected cells detected both nsp1 and nsp8 but not nsp2,
as expected. This indicated that processing was occurring at the
junction between nsp1 and FFL/GFP and that expression and pro-
cessing of downstream proteins from the replicase polyprotein
were intact. Immunoprecipitation with anti-nsp3 in WT-infected
cells detected the 210-kDa nsp3 as well as the known nsp2-nsp3
intermediate precursor (275 kDa). In contrast, a 210-kDa nsp3
protein was barely detectable following infection with MHV-2-
FFL3 and not detected from cells infected with MHV-2-GFP3.
Instead, anti-nsp3 antibodies detected a protein of 271 kDa in
MHV-2-FFL3-infected cells (the predicted mobility of nsp3 plus
FFL) and a protein of237 kDa in MHV-2-GFP3-infected cells
(the predicted mobility of nsp3 plus GFP). These results indicate
that reporter molecules are efficiently processed at the nsp1-re-
porter junctions but minimally or not processed at the engineered
cleavage sites between the reporter and nsp3. This suggested that
while P1= to P5= residues are required for cleavage, the context of
P5-P1 is also important. This result serendipitously demonstrated
that viable recombinant MHV could be engineered with a reporter
fusion with the 210-kDa nsp3 protein.
This outcome served as the rationale for the design of the “sec-
ond-generation” reporters, with a retained cleavage site between
nsp1 and the reporter and a deletion of the cleavage site between
the reporter and nsp2. For MHV-GFP2 and MHV-FFL2, immu-
FIG 1 Generation and recovery of MHV replicase reporter viruses. (A) Sche-
matic of MHV genome organization with ORF1a and ORF1b connected by a
ribosomal frameshift (RFS) and downstream structural/accessory ORFs. S,
spike; E, envelope; M, membrane; N, nucleocapsid. The ORF1ab polyprotein
of MHV is shown with nonstructural protein domains 1 to 16 (nsp). Papain-
like proteinase domains PL1 and PL2 are indicated by gray and white boxes,
respectively, in nsp3. The nsp5 protease (3CLpro and Mpro) is indicated by the
black box. Cleavages mediated by each domain are indicated by correspond-
ingly colored arrowheads (CS1, cleavage site 1). Deletion is indicated byo. (B)
Design of reporter fusion viruses. The top schematic shows WT MHV-A59
nsp1-nsp3 with cleavage site residues P5-P2=, with cleavage sites marked by
carets. The next schematics show previously described MHV-CS2 (lacking
P1 Gly at the nsp2-3 cleavage site) and MHV-nsp2 with an in-frame deletion
of nsp2 and a functional engineered nsp1-nsp3 cleavage site. GFP and FFL
reporter gene insertions are indicated in gray. All confirmed functional cleav-
ages are indicated by gray arrowheads. MHV-2-GFP/FFL3, MHV with a
deletion of nsp2 and fusion of GFP or FFL to nsp3; MHV-GFP/FFL2, MHV
with the addition of GFP or FFL as a fusion to nsp2.
FIG 2 Polyprotein expression and processing in MHV replicase reporter vi-
ruses. (A) DBT cells were infected with WT MHV, MHV-2-GFP3 (G3), and
MHV-2-FFL3 (F3). Radiolabeled proteins were immunoprecipitated by
combined antibodies for nsp1, nsp3, and nsp8 and detected by fluorography.
Molecular mass markers are indicated on the left. nsp3, nsp2-3, FFL-nsp3, and
GFP-nsp3 are indicated. m, mock. (B) DBT cells were infected with WT MHV,
MHV-GFP2 (G2), and MHV-FFL2 (F2), as indicated by the top labels, and
radiolabeled proteins were harvested by immunoprecipitation and detected by
fluorography. Antibodies used are indicated to the right or at the top. The
dashed line represents the same gel with different exposure times: overnight on
the left and 1 week on the right. Molecular mass markers are indicated on the
left. nsp2, GFP-nsp2, and FFL-nsp2 are indicated by white arrowheads.
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noprecipitation of infected cell lysates with anti-nsp1 and anti-
nsp8 detected the respective proteins. Antibodies against nsp2 de-
tected the 65-kDa nsp2 in WT-infected lysates but did not detect
nsp2 in either reporter virus. Instead, anti-nsp2 immunoprecipi-
tated proteins of 92 kDa or 126 kDa, consistent with the predicted
sizes of the GFP-nsp2 and FFL-nsp2 fusion proteins, respectively
(Fig. 2B). To confirm this, we immunoprecipitated lysates with
anti-GFP and anti-FFL antibodies. Anti-FFL detected a protein
from MHV-FFL2-infected cells with a mobility identical to that
detected by anti-nsp2. The anti-GFP immunoprecipitation of
MHV-GFP2-infected lysates detected a protein with a mobility
differing slightly from that of anti-nsp2 but consistent with a fu-
sion of nsp2-GFP. The reason for the difference in mobility is not
clear but suggests different migrating forms of nsp2-GFP with
different available epitopes recognized by anti-nsp2 and anti-
GFP. The complete lack of nsp2 and the detection of new proteins
consistent with nsp2-GFP and nsp2-FFL strongly supported the
expression of stable fusion proteins that are not cleaved during
infection. Overall, these results indicated that the recombinant
viruses expressed the reporters as fusions with nsp3 or with nsp2.
Replication of MHV-2-GFP3, MHV-2-FFL3, MHV-
GFP2, and MHV-FFL2. Previous work in our laboratory has
shown that MHV-nsp2 replicates with kinetics similar to those
of WT MHV but with a lower peak titer (26), while MHV mutants
engineered to abolish cleavage site 2 between nsp2 and nsp3
(MHV-CS2) demonstrated a prolonged eclipse phase but ulti-
mately achieved WT-like peak titers (36). Finally, a loss of cleavage
between nsp1 and nsp2 has been demonstrated to result in a de-
creased viral yield but WT-like timing of exponential replication
(37). To test the effect of reporter fusions with nsp2 or nsp3, we
infected murine DBT cells with MHV-2-GFP3, MHV-2-FFL3,
MHV-GFP2, or MHV-FFL2 in direct comparison with WT MHV,
MHV-nsp2, and MHV-CS2, with measurement of superna-
tant virus titers by plaque assays at multiple time points postinfec-
tion (Fig. 3). MHV-nsp2 replicated with a 1-log10 impairment in
viral titers but normal timing of exponential replication. MHV-
CS2 (nsp2-3 fusion) also replicated as previously reported, with
delayed exponential replication but WT-like virus yield. MHV-
2-GFP3 and MHV-2-FFL3 replication resulted in a cumulative
phenotype: a 4-h delay in exponential replication similar to that of
MHV-CS2 and a decreased viral yield similar to that of MHV-
nsp2. In contrast, both MHV-GFP2 and MHV-FFL2 demon-
strated replication in culture with exponential replication and vi-
ral yields similar to those of WT MHV. This suggests that the
replication phenotypes of MHV-2-GFP3 and MHV-2-FFL3
result from the deletion of nsp2 and the fusion of nsp2 with nsp3
and not from the insertion of foreign genes themselves. These
results support our previous studies proposing that cleavage at the
nsp3 N terminus is required for efficient onset of exponential
replication (36). Similarly, the WT-like replication of MHV-GFP2
and MHV-FFL2 further shows that it is cleavage at the C terminus
of nsp1 that is required for a WT-like yield. Finally, the results
demonstrate that expansion of the replicase gene and polyprotein
can still allow for WT-like replication.
Subcellular localization of nsp2 and nsp3 fusion reporters.
We next tested the expression and localization of nsp2 and nsp3
reporter fusions in virus-infected cells. DBT cells on glass cover-
slips were infected with reporter-expressing MHV at an MOI of 1
PFU/cell, fixed at 10 h p.i., stained for replicase proteins, and ex-
amined by confocal microscopy (Fig. 4). DBT cells infected with
WT MHV and stained with antibodies for nsp2, nsp3, nsp8, or
membrane (M) protein demonstrated the established punctate
cytoplasmic pattern of localization (Fig. 4A). Cells infected with
MHV-2-GFP3 or MHV-2-FFL3 also exhibited a punctate,
perinuclear cytoplasmic localization of reporter molecules by na-
tive fluorescence (GFP) or by IF with anti-FFL. Both GFP and FFL
colocalized with nsp8 (Fig. 4B), a replicase protein known to lo-
calize to replication complexes, but were distinct from M, which
localizes to sites of viral assembly in the ERGIC/Golgi compart-
ment (Fig. 4A and data not shown for FFL). The punctate nature
of the reporter localization suggests a mechanism for specific tar-
geting to replication complexes. In addition, these results demon-
strate that GFP fluorescence is intact when the reporter is fused to
the N terminus of nsp3. DBT cells infected with MHV-GFP2 (Fig.
4C) also exhibited a punctate, perinuclear cytoplasmic localiza-
tion and colocalized with nsp2 and nsp8, again demonstrating
specific targeting to replication complexes and indicating that na-
tive fluorescence is intact in the nsp2-reporter fusion protein.
Competitive fitness of WT MHV versus MHV-GFP2. Since
MHV-FFL2 and MHV-GFP2 demonstrated WT-like kinetics dur-
ing replication in culture, we tested whether there was a fitness
cost associated with the introduction of a foreign protein into the
replicase polyprotein. Cells were infected with WT MHV or
MHV-GFP2 alone or at a WT MHV/MHV-GFP2 ratio of 1:1,
1:10, or 10:1 at a combined MOI of 0.1 PFU/cell, followed by 10
passages of supernatant into fresh flasks of DBT cells. We then
compared GFP expression with the expression of the replicase
protein nsp8 to determine the relative competitiveness of MHV-
GFP2. DBT cells seeded onto glass coverslips were infected with
P1, P3, and P10 passages of each combination of viruses for 8 h.
Following immunostaining for nsp8, coverslips were imaged and
scored for nsp8 (indirect immunofluorescence [red]) and GFP
(native green fluorescence). At all passages, WT MHV-infected
cells exhibited only an nsp8 (red) signal, while MHV-GFP2-in-
fected cells demonstrated colocalized nsp8 (red) and native GFP
signals in all cells (Fig. 5). In competition experiments, at P1,
MHV-GFP2-infected cells were detected but not at levels equiva-
FIG 3 Replication of MHV reporter fusion viruses. DBT cells were infected
with recombinant WT MHV, MHV-nsp2, MHV-CS2, MHV-2-GFP3,
MHV-2-FFL3, MHV-GFP2, and MHV-FFL2 at an MOI of 1 PFU/cell. The
supernatant was sampled at the indicated times p.i., and titers were determined
by plaque assays. Titers reported are the averages of three replicates	 standard
deviations.
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lent to the input ratios. By P3 to P10, even when a 10-fold advan-
tage was given to MHV-GFP2, the recombinant virus could not
compete with the WT. Thus, while GFP as a fusion with nsp2 had
no effect on replication as measured by plaque assays, the inser-
tion of the gene was associated with a fitness cost compared to the
WT virus.
MHV-GFP2 allows quantitation of replication complex for-
mation in live cells.We tested whether reporter-nsp fusions could
be used to track the quantity and movement of these proteins
within a single infected cell over time. DBT cells cultured in glass-
bottomed dishes were infected with MHV-GFP2, and at 5 h p.i.,
they were imaged in a live-imaging chamber incubator at 37°C on
a wide-field fluorescence microscope. Images were collected in the
differential interference contrast (DIC) and green filter sets every
30 s for 2.5 h from the same field (Fig. 6; see also Fig. S1 in the
supplemental material). Every 10th image was analyzed for cor-
rected total cell fluorescence (CTCF) by selecting the cell as the
region of interest (ROI) and correcting for the background within
each individual image (38). Green fluorescence was evident from
the first frame, and the CTCF value nearly tripled throughout
infection, until it peaked at 6.75 h p.i. At the conclusion of imaging
at 7.5 h p.i., the CTCF value decreased from the peak value by
30%. Throughout the collection of images, green fluorescence was
localized perinuclearly, with increasing numbers and intensities of
GFP foci from 5 to 7.5 h p.i. The increase in fluorescence intensity
during infection indicates that more copies of GFP-nsp2 are being
produced and accumulating, as each copy of nsp2 is fused to only
FIG 4 MHV nsp2 and nsp3 fusion reporters localize to replication complexes.
DBT cells were infected with WT MHV (A), MHV-2-GFP3 or MHV-2-
FFL3 (B), or MHV-GFP2 (C). At 10 h p.i., cells were fixed, stained with the
indicated antibodies (anti-FFL, anti-nsp2, anti-nsp3, anti-nsp8, and anti-M),
and imaged by confocal microscopy. GFP was detected by native fluorescence.
FIG 5 Competitive fitness of WT MHV and MHV-GFP2. DBT cells were
infected with WT MHV or MHV-GFP2 alone or at a 1:1, 1:10, or 10:1 ratio of
WT MHV to MHV-GFP2. DBT cells on glass coverslips were infected at an
MOI of 1 PFU/cell with P1, P3, and P10 passages of each combination. At 8 h
p.i., cells were fixed and imaged for nsp8 (red) and GFP (green). Cells contain-
ing green (MHV-GFP2) or red (WT MHV or MHV-GFP2) replication com-
plexes were scored. Thirty images from two independent experiments were
obtained and scored for cells infected only with WT MHV or only with MHV-
GFP2, while for the samples infected with WT MHV and MHV-GFP2 at 1:1,
1:10, and 10:1 ratios, 50 images from two independent experiments were
scored.
FIG6 MHV-GFP2 quantitation of replication complex formation in live cells.
(A) DBT cells on glass-bottom culture dishes were infected with MHV-GFP2
at an MOI of 1 PFU/cell. At 5 h p.i., dishes were transferred to a chamber
incubator at 37°C, with imaging of DIC and GFP every 30 s for 2.5 h. Individual
frames were used to generate this panel. The video sequence corresponding to
this figure can be found in Fig. S1 in the supplemental material. (B) Corrected
total cell fluorescence (CTCF) was measured for the cell by utilizing ImageJ.
CTCF was calculated for every 10 frames and plotted over time. Data shown
were calculated from three independent infected cells.
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one fluorescent molecule, in contrast to indirect fluorescence,
where multiple fluorescent molecules have the capacity to bind to
one viral protein. These results indicate that the reporter viruses
MHV-GFP2 and MHV-2-GFP3 can be used to directly measure
the progression of RC formation in real time in single infected
cells as well as to track the localization and movement of nsp2 and
nsp3 over time.
Use of MHV-FFL2 and MHV-2-FFL3 for quantitation of
early virus replication. Translation of input genome RNA is the
first step in virus replication, and ORF1a, encoding the nsp2 and
nsp3 domains, is translated 100% of the time. We hypothesized
that this would allow translation of luciferase to provide an earlier
marker of viral replication. We inquired whether FFL expressed as
fusions with nsp2 or nsp3 could be used to quantitatively measure
replication and, if so, whether it was as sensitive as determination
of virus titers. DBT cells were infected with MHV-FFL2 or MHV-
2-FFL3 at an MOI of 1 PFU/cell, supernatants were collected for
plaque assays, and cells were harvested for luciferase assays at mul-
tiple times postinfection (Fig. 7). Both MHV-FFL2 and MHV-2-
FFL3 replicated as expected, with MHV-2-FFL3 demonstrating
delayed exponential replication and decreases in virus yield com-
pared to MHV-FFL2. Luciferase activity (yield in relative light
units [RLU]) for MHV-FFL2 showed a signal3 log10 higher than
the corresponding titer at 4 h p.i. while increasing in signal over
time. At 8 h p.i., measurements of luciferase activity and titers
were very similar. MHV-2-FFL3-infected cells also demon-
strated a3-log10 increase in FFL signal compared to viral titers at
4 h p.i., but this increased signal was retained until 16 h p.i. Most
importantly, for both viruses, FFL activity was detected earlier and
was 100-fold higher than the virus titer during the eclipse phase.
The amplification trend for MHV-FFL2 luminescence mirrors
replication, as does the trend for MHV-2-FFL3, suggesting that
this assay can serve as a robust early surrogate for viral replication.
Furthermore, the results demonstrate that replicase gene transla-
tion is occurring continuously and that the genome used as a
translational template is being amplified, even in virus with a de-
layed exponential increase in virus titers. These results establish
that the expression of the FFL reporter from the MHV replicase
serves as a sensitive, quantitative marker of replicase polyprotein
translation and as a discriminating indicator of viral replication.
These results also suggest that it may be possible to uncouple mea-
surements of genome translation and genome replication from
measurements of infectious virus, which might act as a much ear-
lier biological marker for studies of virus inhibition or studies or
constitutive or conditional mutations.
DISCUSSION
In this study, we demonstrate that the CoV genome is capable of
tolerating large substitutions or additions of foreign genetic ma-
terial within the replicase protein as in-frame protein domains.
Furthermore, we show that the fusion of reporters to replicase
proteins is tolerated in efficiently replicating virus, allowing quan-
titative assessments of multiple stages of the virus life cycle. Spe-
cifically, these studies show that measurement of viral replication
by using FFL can be a highly sensitive, early, and powerful surro-
gate for genome replication and that GFP fusions with nsp2 and
nsp3 can allow quantitative assessments of replication complex
formation and evolution during the course of infection. Finally,
the results show that insertions of very different proteins are tol-
erated at each of these locations.
Most studies of CoV replication using the addition of reporters
have involved the substitution of accessory ORFs. These ORFs
have been used as general indicators of overall viral replication,
mostly for testing of inhibitors or attenuation of replication (19–
24, 39–41). However, these strategies are limited as direct indica-
tors of genome replication, since they require subgenomic mRNA
transcription for expression of the engineered reporters or are not
contained within infectious virus. While reporters expressed from
downstream ORFs are valuable as indicators of overall viral repli-
cation, they cannot distinguish genome replication from sub-
genomic mRNA transcription. Reporters have also been em-
ployed for analysis of coronavirus host interactions and cell
biology. Specifically, the expression of nsp2-reporter or nsp4-re-
porter fusions as substitutions of MHV ORF4 or hemagglutinin
esterase (HE) has been described and used to define the localiza-
tion and movement of nsp’s (42–44). While informative, these
studies are limited in their interpretation by nsp expression from
nonnative locations in the genome. We have shown that alterna-
tive expression of nsp2 can be detrimental to replication, even
when expressed as a duplication with native nsp2 (44). Our results
suggest that the context of the nsp2 location in the polyprotein is
important for its interaction with adjacent replicase proteins. Al-
though nsp2 is dispensable for replication (26), altering expres-
sion by a deletion or cleavage site alteration impacts replication
and fitness.
The observation that GFP or FFL fusions with nsp2 had no
detectable effect on the MHV replication cycle in culture was sur-
prising and suggests significant flexibility in this region of the
polyprotein for additional genetic information. A recent study of
the evolution of the genomes of nidoviruses from the small arteri-
viruses (15 kb) to the largest coronaviruses (up to 32 kb) pro-
posed that proto-CoVs emerged due to the incorporation of a
cassette of proteins, including the proofreading exonuclease in
nsp14, which allowed more stability of larger genomes (45). It was
also proposed that an increased genetic robustness to mutations
FIG 7 MHV-FFL2 and MHV-2-FFL3 are quantitative measures of replica-
tion. DBT cells were infected with MHV-2-FFL3 or MHV-FFL2 at an MOI of
1 PFU/cell in replicate wells. At the indicated times p.i., the supernatant was
collected for measurement of virus titers by plaque assays, and cells were har-
vested for measurement of FFL activity. Titers (PFU) (solid lines) and lumi-
nescence (RLU) (dotted lines) are plotted. Data are represented as means 	
standard deviations of three replicates.
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was also required for genome expansion and increased complex-
ity. Our study supports that argument, with the incorporation of
FFL expanding the MHV genome by 5.3%. The virus can be
recovered at P0 and P1 with high-titer stocks for use in vitro and in
vivo, and the FFL coding sequence is maintained for at least 5
passages. However, the introduction of GFP as an nsp2 fusion
results in a fitness cost during direct competition with MHV. It
will be interesting to see if this fitness cost is similar for FFL or
other foreign genes. It will also be of interest to see whether foreign
genes are retained over a long passage in the absence of competi-
tion or if the subtle fitness cost results in selection against the
foreign sequences in the long term.
The implications of stable replicase nsp-reporter fusions are
significant for several reasons. It was not previously possible to
directly quantitate the translation of the CoV replicase/transcrip-
tase polyproteins in infected cells. CoV ORF1a expresses a495-
kDa polyprotein (pp1a). Translation of ORF1b, which encodes
critical replication enzymes, including nsp12–RNA-dependent
RNA polymerase (RdRp) and nsp14-ExoN, requires a ribosomal
frameshift between nsp10 and nsp12. Previous in vitro studies
suggested that frameshift efficiencies range from 10 to 40% (46).
Dual-luciferase systems have been used to examine structures and
sequences in this region; however, this has never been tested by
utilizing infectious virus (47, 48). Expression of different quanti-
tative reporters from ORF1a and ORF1b could allow direct testing
of the timing and stoichiometry of replicase polyprotein transla-
tion. We have recently recovered recombinant viruses expressing
GFP as a fusion with nsp14 (our unpublished results), providing
encouraging evidence that ORF1b reporter expression is possible.
The early exponential signal from FFL-nsp2 is consistent with a
rapid amplification of genome RNA prior to virus assembly and
release and thus may be an early and sensitive reporter for studies
of inhibitors of virus replication. Similarly, it was not previously
possible to track the expression and localization of replicase pro-
teins from their native locations in the genome. The native expres-
sion of fluorescent reporters fused to replicase proteins creates the
opportunity to track replication complex formation in real time in
a single cell, without potential artifacts due to cellular fixation for
immunofluorescence or due to altered expression from sub-
genomic mRNAs or exogenous plasmids. Our results suggest that
it may be possible to engineer reporter fusions with multiple rep-
licase proteins for testing and visualization of protein-protein and
protein-membrane interactions in live cells.
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